MediCheck Member Medical Aid Complaint Assessment (Doctor Submission)
Doctor-submitted form for MediCheck member complaints. Please ensure you have obtained patient consent before completing and sending this form directly to MediCheck.
Patient Full Name
*
First Name
Last Name
Patient Date of Birth
*
-
Month
-
Day
Year
2 digit month, 2 digit day, 4 digit year
Date
Medical Aid Scheme
*
Please Select
AECI MEDICAL AID SOCIETY
ALLIANCE-MIDMED MEDICAL SCHEME
ANGLO MEDICAL SCHEME
ANGLOVAAL GROUP MEDICAL SCHEME
BANKMED
BARLOWORLD MEDICAL SCHEME
BESTMED MEDICAL SCHEME
BMW EMPLOYEES MEDICAL AID SOCIETY
BONITAS MEDICAL FUND
BP MEDICAL AID SOCIETY
BUILDING & CONSTRUCTION INDUSTRY MEDICAL AID FUND
CAPE MEDICAL PLAN
CHARTERED ACCOUNTANTS (SA) MEDICAL AID FUND (CAMAF)
COMPCARE WELLNESS MEDICAL SCHEME
DE BEERS BENEFIT SOCIETY
DISCOVERY HEALTH MEDICAL SCHEME
ENGEN MEDICAL BENEFIT FUND
FEDHEALTH MEDICAL SCHEME
FISHING INDUSTRY MEDICAL SCHEME (FISH-MED)
FOODMED MEDICAL SCHEME
GENESIS MEDICAL SCHEME
GLENCORE MEDICAL SCHEME
GOLDEN ARROW EMPLOYEES MEDICAL BENEFIT FUND
GOVERNMENT EMPLOYEES MEDICAL SCHEME (GEMS)
HORIZON MEDICAL SCHEME
IMPALA MEDICAL PLAN
IMPERIAL GROUP MEDICAL SCHEME
KEYHEALTH MEDICAL SCHEME
LA-HEALTH MEDICAL SCHEME
LIBCARE MEDICAL SCHEME
LONMIN MEDICAL SCHEME
MAKOTI MEDICAL SCHEME
MALCOR MEDICAL AID SCHEME
MASSMART HEALTH PLAN
MBMED MEDICAL AID FUND
MEDIHELP MEDICAL SCHEME
MEDIMED MEDICAL SCHEME
MEDIPOS MEDICAL SCHEME
MEDSHIELD MEDICAL SCHEME
MOMENTUM MEDICAL SCHEME
MOTOHEALTH CARE
MULTICHOICE MEDICAL AID SCHEME
NETCARE MEDICAL SCHEME
OLD MUTUAL STAFF MEDICAL AID FUND
PARMED MEDICAL AID SCHEME
PG GROUP MEDICAL SCHEME
PICK N PAY MEDICAL SCHEME
PLATINUM HEALTH
PROFMED
RAND WATER MEDICAL SCHEME
REMEDI MEDICAL AID SCHEME
RETAIL MEDICAL SCHEME
RHODES UNIVERSITY MEDICAL SCHEME
SA BREWERIES MEDICAL AID SOCIETY (SABMAS)
SABC MEDICAL SCHEME
SOUTH AFRICAN MUNICIPAL UNION NATIONAL MEDICAL SCHEME (SAMWUMED)
SASOLMED
SEDMED
SISONKE HEALTH MEDICAL SCHEME
SIZWE HOSMED MEDICAL FUND
SOUTH AFRICAN POLICE SERVICE MEDICAL SCHEME (POLMED)
SUREMED HEALTH
TFG MEDICAL AID SCHEME
THEBEMED MEDICAL SCHEME
TIGER BRANDS MEDICAL SCHEME
TRANSMED MEDICAL FUND
TSOGO SUN GROUP MEDICAL SCHEME
UMVUZO HEALTH MEDICAL SCHEME
UNIVERSITY OF KWAZULU NATAL MEDICAL SCHEME
WITBANK COALFIELDS MEDICAL AID SOCIETY (WCMAS)
WOOLTRU HEALTHCARE FUND
Medical Aid Number
*
Patient Contact Number
*
Please enter a valid phone number.
Format: (000) 000-0000.
Patient Email Address
*
example@example.com
Patient Contact Address
*
Street Address
Street Address Line 2
City
State / Province
Postal / Zip Code
Please Select
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
The Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Cote d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Polynesia
Gabon
The Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
North Korea
South Korea
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Nagorno-Karabakh
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Turkish Republic of Northern Cyprus
Northern Mariana
Norway
Oman
Pakistan
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Republic of the Congo
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
Somaliland
South Africa
South Ossetia
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard
eSwatini
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Transnistria Pridnestrovie
Trinidad and Tobago
Tristan da Cunha
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
British Virgin Islands
Isle of Man
US Virgin Islands
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Other
Country
Doctor Full Name
*
First Name
Last Name
Doctor Practice Number
*
Doctor Contact Number
*
Please enter a valid phone number.
Format: (000) 000-0000.
Doctor Email Address
*
example@example.com
Is this a CDL or PMB Condition
*
Yes
No
Chronic Condition ICD10 Code
Please Select
E27.1 Primary adrenocortical insufficiency (Addison's disease)
J45 Asthma
F20 Schizophrenia
F31 Bipolar mood disorder
J47 Bronchiectasis
I50.9 Heart failure, unspecified
I42.9 Cardiomyopathy, unspecified
J44.9 Chronic obstructive pulmonary disease, unspecified (COPD)
N18.9 Chronic renal failure, unspecified
I25.1 Atherosclerotic heart disease (Coronary artery disease)
K50.9 Crohn's disease, unspecified
E23.2 Diabetes insipidus
E10.9 Type 1 diabetes mellitus without complications
E11.9 Type 2 diabetes mellitus without complications
I48.9 Atrial fibrillation and atrial flutter (Dysrhythmias)
G40.9 Epilepsy, unspecified
H40.9 Glaucoma, unspecified
D66 Hereditary factor VIII deficiency (Haemophilia A)
B20 Human immunodeficiency virus [HIV] disease
E78.5 Hyperlipidaemia, unspecified
I10 Essential (primary) hypertension
E03.9 Hypothyroidism, unspecified
G35 Multiple sclerosis
G20 Parkinson's disease
M06.9 Rheumatoid arthritis, unspecified
M32.9 Systemic lupus erythematosus, unspecified
K51.9 Ulcerative colitis, unspecified
Prescribed Minimum Benefit (PMB Code - Map to ICD10 Code above)
Please Select
A80.0 - Acute paralytic poliomyelitis, vaccine-associated (PMB 906A: Acute generalised paralysis, including polio and Guillain-Barre)
A80.1 - Acute paralytic poliomyelitis, wild virus, imported (PMB 906A: Acute generalised paralysis, including polio and Guillain-Barre)
A80.2 - Acute paralytic poliomyelitis, wild virus, indigenous (PMB 906A: Acute generalised paralysis, including polio and Guillain-Barre)
A80.3 - Acute paralytic poliomyelitis, other and unspecified (PMB 906A: Acute generalised paralysis, including polio and Guillain-Barre)
A80.9 - Acute poliomyelitis, unspecified (PMB 906A: Acute generalised paralysis, including polio and Guillain-Barre)
B91 - Sequelae of poliomyelitis (PMB 906A: Acute generalised paralysis, including polio and Guillain-Barre)
G14 - Postpolio syndrome (PMB 906A: Acute generalised paralysis, including polio and Guillain-Barre)
G61.0 - Guillain-Barré syndrome (PMB 906A: Acute generalised paralysis, including polio and Guillain-Barre)
G61.1 - Serum neuropathy (PMB 906A: Acute generalised paralysis, including polio and Guillain-Barre)
G61.8 - Other inflammatory polyneuropathies (PMB 906A: Acute generalised paralysis, including polio and Guillain-Barre)
G61.9 - Inflammatory polyneuropathy, unspecified (PMB 906A: Acute generalised paralysis, including polio and Guillain-Barre)
G20 - Parkinson's disease (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G21.1 - Other drug-induced secondary parkinsonism (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G21.2 - Secondary parkinsonism due to other external agents (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G21.3 - Postencephalitic parkinsonism (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G21.4 - Vascular parkinsonism (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G21.8 - Other secondary parkinsonism (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G21.9 - Secondary parkinsonism, unspecified (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G22 - Parkinsonism in diseases classified elsewhere (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G23.0 - Hallervorden-Spatz disease (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G23.1 - Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski] (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G23.2 - Striatonigral degeneration (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G23.8 - Other specified degenerative diseases of basal ganglia (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G23.9 - Degenerative disease of basal ganglia, unspecified (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G24.0 - Drug-induced dystonia (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G24.1 - Idiopathic familial dystonia (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G24.2 - Idiopathic nonfamilial dystonia (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G24.3 - Spasmodic torticollis (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G24.4 - Idiopathic orofacial dystonia (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G24.8 - Other dystonia (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G24.9 - Dystonia unspecified (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G25.0 - Essential tremor (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G25.1 - Drug-induced tremor (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G25.2 - Other specified forms of tremor (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G25.3 - Myoclonus (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G25.4 - Drug-induced chorea (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G25.5 - Other chorea (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G25.6 - Drug-induced tics and other tics of organic origin (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G25.8 - Other extrapyramidal and movement disorders - Other specified extrapyramidal and movement disorders (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G25.9 - Extrapyramidal and movement disorder unspecified (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
G26 - Extrapyramidal and movement disorders in diseases classified elsewhere (PMB 341A: Basal ganglia, extra-pyramidal disorders; other dystonias NOS)
C70.0 - Malignant neoplasm, cerebral meninges (PMB 950A: Benign and malignant brain tumours, treatable)
C70.0+D63.0* - Malignant neoplasm, cerebral meninges/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C70.0+G13.0* - Malignant neoplasm, cerebral meninges/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C70.0+G13.1* - Malignant neoplasm, cerebral meninges/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C70.1 - Malignant neoplasm, spinal meninges (PMB 950A: Benign and malignant brain tumours, treatable)
C70.1+D63.0* - Malignant neoplasm, spinal meninges/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C70.1+G13.0* - Malignant neoplasm, spinal meninges/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C70.1+G13.1* - Malignant neoplasm, spinal meninges/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C70.9 - Malignant neoplasm, meninges, unspecified (PMB 950A: Benign and malignant brain tumours, treatable)
C70.9+D63.0* - Malignant neoplasm, meninges, unspecified/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C70.9+G13.0* - Malignant neoplasm, meninges, unspecified/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C70.9+G13.1* - Malignant neoplasm, meninges, unspecified/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C71.0 - Malignant neoplasm, cerebrum except lobes and ventricles (PMB 950A: Benign and malignant brain tumours, treatable)
C71.0+D63.0* - Malignant neoplasm, cerebrum except lobes and ventricles/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C71.0+G13.0* - Malignant neoplasm, cerebrum except lobes and ventricles/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C71.0+G13.1* - Malignant neoplasm, cerebrum except lobes and ventricles/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C71.1 - Malignant neoplasm, frontal lobe (PMB 950A: Benign and malignant brain tumours, treatable)
C71.1+D63.0* - Malignant neoplasm, frontal lobe/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C71.1+G13.0* - Malignant neoplasm, frontal lobe/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C71.1+G13.1* - Malignant neoplasm, frontal lobe/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C71.2 - Malignant neoplasm, temporal lobe (PMB 950A: Benign and malignant brain tumours, treatable)
C71.2+D63.0* - Malignant neoplasm, temporal lobe/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C71.2+G13.0* - Malignant neoplasm, temporal lobe/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C71.2+G13.1* - Malignant neoplasm, temporal lobe/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C71.3 - Malignant neoplasm, parietal lobe (PMB 950A: Benign and malignant brain tumours, treatable)
C71.3+D63.0* - Malignant neoplasm, parietal lobe/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C71.3+G13.0* - Malignant neoplasm, parietal lobe/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C71.3+G13.1* - Malignant neoplasm, parietal lobe/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C71.4 - Malignant neoplasm, occipital lobe (PMB 950A: Benign and malignant brain tumours, treatable)
C71.4+D63.0* - Malignant neoplasm, occipital lobe/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C71.4+G13.0* - Malignant neoplasm, occipital lobe/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C71.4+G13.1* - Malignant neoplasm, occipital lobe/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C71.5 - Malignant neoplasm, cerebral ventricle (PMB 950A: Benign and malignant brain tumours, treatable)
C71.5+D63.0* - Malignant neoplasm, cerebral ventricle/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C71.5+G13.0* - Malignant neoplasm, cerebral ventricle/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C71.5+G13.1* - Malignant neoplasm, cerebral ventricle/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C71.6 - Malignant neoplasm, cerebellum (PMB 950A: Benign and malignant brain tumours, treatable)
C71.6+D63.0* - Malignant neoplasm, cerebellum/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C71.6+G13.0* - Malignant neoplasm, cerebellum/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C71.6+G13.1* - Malignant neoplasm, cerebellum/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C71.7 - Malignant neoplasm, brain stem (PMB 950A: Benign and malignant brain tumours, treatable)
C71.7+D63.0* - Malignant neoplasm, brain stem/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C71.7+G13.0* - Malignant neoplasm, brain stem/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C71.7+G13.1* - Malignant neoplasm, brain stem/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C71.8 - Malignant neoplasm, overlapping lesion of brain (PMB 950A: Benign and malignant brain tumours, treatable)
C71.8+D63.0* - Malignant neoplasm, overlapping lesion of brain/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C71.8+G13.0* - Malignant neoplasm, overlapping lesion of brain/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C71.8+G13.1* - Malignant neoplasm, overlapping lesion of brain/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C71.9 - Malignant neoplasm, brain, unspecified (PMB 950A: Benign and malignant brain tumours, treatable)
C71.9+D63.0* - Malignant neoplasm, brain, unspecified/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C71.9+G13.0* - Malignant neoplasm, brain, unspecified/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C71.9+G13.1* - Malignant neoplasm, brain, unspecified/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C72.0 - Malignant neoplasm, spinal cord (PMB 950A: Benign and malignant brain tumours, treatable)
C72.0+D63.0* - Malignant neoplasm, spinal cord/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C72.0+G13.0* - Malignant neoplasm, spinal cord/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C72.0+G13.1* - Malignant neoplasm, spinal cord/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C72.1 - Malignant neoplasm, cauda equina (PMB 950A: Benign and malignant brain tumours, treatable)
C72.1+D63.0* - Malignant neoplasm, cauda equina/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C72.1+G13.0* - Malignant neoplasm, cauda equina/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C72.1+G13.1* - Malignant neoplasm, cauda equina/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C72.2 - Malignant neoplasm, olfactory nerve (PMB 950A: Benign and malignant brain tumours, treatable)
C72.2+D63.0* - Malignant neoplasm, olfactory nerve/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C72.2+G13.0* - Malignant neoplasm, olfactory nerve/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C72.2+G13.1* - Malignant neoplasm, olfactory nerve/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C72.3 - Malignant neoplasm, optic nerve (PMB 950A: Benign and malignant brain tumours, treatable)
C72.3+D63.0* - Malignant neoplasm, optic nerve/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C72.3+G13.0* - Malignant neoplasm, optic nerve/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C72.3+G13.1* - Malignant neoplasm, optic nerve/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C72.4 - Malignant neoplasm, acoustic nerve (PMB 950A: Benign and malignant brain tumours, treatable)
C72.4+D63.0* - Malignant neoplasm, acoustic nerve/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C72.4+G13.0* - Malignant neoplasm, acoustic nerve/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C72.4+G13.1* - Malignant neoplasm, acoustic nerve/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C72.5 - Malignant neoplasm, other and unspecified cranial nerves (PMB 950A: Benign and malignant brain tumours, treatable)
C72.5+D63.0* - Malignant neoplasm, other and unspecified cranial nerves/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C72.5+G13.0* - Malignant neoplasm, other and unspecified cranial nerves/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C72.5+G13.1* - Malignant neoplasm, other and unspecified cranial nerves/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C72.8 - Malignant neoplasm, overlapping lesion of brain and other parts of central nervous system (PMB 950A: Benign and malignant brain tumours, treatable)
C72.8+D63.0* - Malignant neoplasm, overlapping lesion of brain and other parts of central nervous system/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C72.8+G13.0* - Malignant neoplasm, overlapping lesion of brain and other parts of central nervous system/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C72.8+G13.1* - Malignant neoplasm, overlapping lesion of brain and other parts of central nervous system/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C72.9 - Malignant neoplasm, central nervous system, unspecified (PMB 950A: Benign and malignant brain tumours, treatable)
C72.9+D63.0* - Malignant neoplasm, central nervous system, unspecified/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C72.9+G13.0* - Malignant neoplasm, central nervous system, unspecified/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C72.9+G13.1* - Malignant neoplasm, central nervous system, unspecified/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
C79.3 - Secondary malignant neoplasm of brain and cerebral meninges (PMB 950A: Benign and malignant brain tumours, treatable)
C79.3+D63.0* - Secondary malignant neoplasm of brain and cerebral meninges/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
C79.3+G13.0* - Secondary malignant neoplasm of brain and cerebral meninges/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
C79.3+G13.1* - Secondary malignant neoplasm of brain and cerebral meninges/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D32.0 - Benign neoplasm, cerebral meninges (PMB 950A: Benign and malignant brain tumours, treatable)
D32.0+D63.0* - Benign neoplasm, cerebral meninges/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D32.0+G13.0* - Benign neoplasm, cerebral meninges/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D32.0+G13.1* - Benign neoplasm, cerebral meninges/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D32.1 - Benign neoplasm, spinal meninges (PMB 950A: Benign and malignant brain tumours, treatable)
D32.1+D63.0* - Benign neoplasm, spinal meninges/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D32.1+G13.0* - Benign neoplasm, spinal meninges/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D32.1+G13.1* - Benign neoplasm, spinal meninges/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D32.9 - Benign neoplasm, meninges, unspecified (PMB 950A: Benign and malignant brain tumours, treatable)
D32.9+D63.0* - Benign neoplasm, meninges, unspecified/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D32.9+G13.0* - Benign neoplasm, meninges, unspecified/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D32.9+G13.1* - Benign neoplasm, meninges, unspecified/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D33.0 - Benign neoplasm, brain, supratentorial (PMB 950A: Benign and malignant brain tumours, treatable)
D33.0+D63.0* - Benign neoplasm, brain, supratentorial/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D33.0+G13.0* - Benign neoplasm, brain, supratentorial/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D33.0+G13.1* - Benign neoplasm, brain, supratentorial/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D33.1 - Benign neoplasm, brain, infratentorial (PMB 950A: Benign and malignant brain tumours, treatable)
D33.1+D63.0* - Benign neoplasm, brain, infratentorial/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D33.1+G13.0* - Benign neoplasm, brain, infratentorial/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D33.1+G13.1* - Benign neoplasm, brain, infratentorial/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D33.2 - Benign neoplasm, brain, unspecified (PMB 950A: Benign and malignant brain tumours, treatable)
D33.2+D63.0* - Benign neoplasm, brain, unspecified/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D33.2+G13.0* - Benign neoplasm, brain, unspecified/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D33.2+G13.1* - Benign neoplasm, brain, unspecified/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D33.3 - Benign neoplasm, cranial nerves (PMB 950A: Benign and malignant brain tumours, treatable)
D33.3+D63.0* - Benign neoplasm, cranial nerves/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D33.3+G13.0* - Benign neoplasm, cranial nerves/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D33.3+G13.1* - Benign neoplasm, cranial nerves/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D33.4 - Benign neoplasm, spinal cord (PMB 950A: Benign and malignant brain tumours, treatable)
D33.4+D63.0* - Benign neoplasm, spinal cord/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D33.4+G13.0* - Benign neoplasm, spinal cord/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D33.4+G13.1* - Benign neoplasm, spinal cord/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D33.7 - Benign neoplasm, other specified parts of central nervous system (PMB 950A: Benign and malignant brain tumours, treatable)
D33.7+D63.0* - Benign neoplasm, other specified parts of central nervous system/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D33.7+G13.0* - Benign neoplasm, other specified parts of central nervous system/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D33.7+G13.1* - Benign neoplasm, other specified parts of central nervous system/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D33.9 - Benign neoplasm, central nervous system, unspecified (PMB 950A: Benign and malignant brain tumours, treatable)
D33.9+D63.0* - Benign neoplasm, central nervous system, unspecified/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D33.9+G13.0* - Benign neoplasm, central nervous system, unspecified/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D33.9+G13.1* - Benign neoplasm, central nervous system, unspecified/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D42.0 - Neoplasm of uncertain/unknown behaviour, cerebral meninges (PMB 950A: Benign and malignant brain tumours, treatable)
D42.0+D63.0* - Neoplasm of uncertain/unknown behaviour, cerebral meninges/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D42.0+G13.0* - Neoplasm of uncertain/unknown behaviour, cerebral meninges/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D42.0+G13.1* - Neoplasm of uncertain/unknown behaviour, cerebral meninges/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D42.1 - Neoplasm of uncertain/unknown behaviour, spinal meninges (PMB 950A: Benign and malignant brain tumours, treatable)
D42.1+D63.0* - Neoplasm of uncertain/unknown behaviour, spinal meninges/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D42.1+G13.0* - Neoplasm of uncertain/unknown behaviour, spinal meninges/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D42.1+G13.1* - Neoplasm of uncertain/unknown behaviour, spinal meninges/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D42.9 - Neoplasm of uncertain/unknown behaviour, meninges, unspecified (PMB 950A: Benign and malignant brain tumours, treatable)
D42.9+D63.0* - Neoplasm of uncertain/unknown behaviour, meninges, unspecified/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D42.9+G13.0* - Neoplasm of uncertain/unknown behaviour, meninges, unspecified/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D42.9+G13.1* - Neoplasm of uncertain/unknown behaviour, meninges, unspecified/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D43.0 - Neoplasm of uncertain/unknown behaviour, brain, supratentorial (PMB 950A: Benign and malignant brain tumours, treatable)
D43.0+D63.0* - Neoplasm of uncertain/unknown behaviour, brain, supratentorial/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D43.0+G13.0* - Neoplasm of uncertain/unknown behaviour, brain, supratentorial/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D43.0+G13.1* - Neoplasm of uncertain/unknown behaviour, brain, supratentorial/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D43.1 - Neoplasm of uncertain/unknown behaviour, brain, infratentorial (PMB 950A: Benign and malignant brain tumours, treatable)
D43.1+D63.0* - Neoplasm of uncertain/unknown behaviour, brain, infratentorial/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D43.1+G13.0* - Neoplasm of uncertain/unknown behaviour, brain, infratentorial/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D43.1+G13.1* - Neoplasm of uncertain/unknown behaviour, brain, infratentorial/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D43.2 - Neoplasm of uncertain/unknown behaviour, brain, unspecified (PMB 950A: Benign and malignant brain tumours, treatable)
D43.2+D63.0* - Neoplasm of uncertain/unknown behaviour, brain, unspecified/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D43.2+G13.0* - Neoplasm of uncertain/unknown behaviour, brain, unspecified/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D43.2+G13.1* - Neoplasm of uncertain/unknown behaviour, brain, unspecified/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D43.3 - Neoplasm of uncertain/unknown behaviour, cranial nerves (PMB 950A: Benign and malignant brain tumours, treatable)
D43.3+D63.0* - Neoplasm of uncertain/unknown behaviour, cranial nerves/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D43.3+G13.0* - Neoplasm of uncertain/unknown behaviour, cranial nerves/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D43.3+G13.1* - Neoplasm of uncertain/unknown behaviour, cranial nerves/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D43.4 - Neoplasm of uncertain/unknown behaviour, spinal cord (PMB 950A: Benign and malignant brain tumours, treatable)
D43.4+D63.0* - Neoplasm of uncertain/unknown behaviour, spinal cord/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D43.4+G13.0* - Neoplasm of uncertain/unknown behaviour, spinal cord/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D43.4+G13.1* - Neoplasm of uncertain/unknown behaviour, spinal cord/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D43.7 - Neoplasm of uncertain/unknown behaviour, other parts of central nervous system (PMB 950A: Benign and malignant brain tumours, treatable)
D43.7+D63.0* - Neoplasm of uncertain/unknown behaviour, other parts of central nervous system/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D43.7+G13.0* - Neoplasm of uncertain/unknown behaviour, other parts of central nervous system/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D43.7+G13.1* - Neoplasm of uncertain/unknown behaviour, other parts of central nervous system/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
D43.9 - Neoplasm of uncertain/unknown behaviour, central nervous system, unspecified (PMB 950A: Benign and malignant brain tumours, treatable)
D43.9+D63.0* - Neoplasm of uncertain/unknown behaviour, central nervous system, unspecified/Anaemia in neoplastic disease (C00-D48+) (PMB 950A: Benign and malignant brain tumours, treatable)
D43.9+G13.0* - Neoplasm of uncertain/unknown behaviour, central nervous system, unspecified/Paraneoplastic neuromyopathy and neuropathy (PMB 950A: Benign and malignant brain tumours, treatable)
D43.9+G13.1* - Neoplasm of uncertain/unknown behaviour, central nervous system, unspecified/Other systemic atrophy primarily affecting central nervous system in neoplastic disease (PMB 950A: Benign and malignant brain tumours, treatable)
S02.00 - Fracture of vault of skull, closed (PMB 49A: Compound/ depressed fractures of skull)
S02.01 - Fracture of vault of skull,open (PMB 49A: Compound/ depressed fractures of skull)
S02.10 - Fracture of base of skull, closed (PMB 49A: Compound/ depressed fractures of skull)
S02.11 - Fracture of base of skull, open (PMB 49A: Compound/ depressed fractures of skull)
S02.70 - Multiple fractures involving skull and facial bones,closed (PMB 49A: Compound/ depressed fractures of skull)
S02.71 - Multiple fractures involving skull and facial bones, open (PMB 49A: Compound/ depressed fractures of skull)
S02.80 - Fractures of other skull and facial bones,closed (PMB 49A: Compound/ depressed fractures of skull)
S02.81 - Fractures of other skull and facial bones,open (PMB 49A: Compound/ depressed fractures of skull)
S02.90 - Fracture of skull and facial bones, part unspecified,closed (PMB 49A: Compound/ depressed fractures of skull)
S02.91 - Fracture of skull and facial bones, part unspecified,open (PMB 49A: Compound/ depressed fractures of skull)
S07.1 - Crushing injury of skull (PMB 49A: Compound/ depressed fractures of skull)
S07.8 - Crushing injury of other parts of head (PMB 49A: Compound/ depressed fractures of skull)
S07.9 - Crushing injury of head, part unspecified (PMB 49A: Compound/ depressed fractures of skull)
T02.00 - Fractures involving head with neck, closed (PMB 49A: Compound/ depressed fractures of skull)
T90.2 - Sequelae of fracture of skull and facial bones (PMB 49A: Compound/ depressed fractures of skull)
G81.0 - Flaccid hemiplegia (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G81.1 - Spastic hemiplegia (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G81.9 - Hemiplegia, unspecified (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G80.0 - Spastic quadriplegic cerebral palsy (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G80.1 - Spastic diplegic cerebral palsy (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G80.2 - Spastic hemiplegic cerebral palsy (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G80.3 - Dyskinetic cerebral palsy (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G80.4 - Ataxic cerebral palsy (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G80.8 - Other cerebral palsy (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G80.9 - Cerebral palsy, unspecified (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G82.0 - Flaccid paraplegia (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G82.1 - Spastic paraplegia (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G82.2 - Paraplegia, unspecified (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G82.3 - Flaccid tetraplegia (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G82.4 - Spastic tetraplegia (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
G82.5 - Tetraplegia, unspecified (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
N31.0 - Uninhibited neuropathic bladder, not elsewhere classified (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
N31.1 - Reflex neuropathic bladder, not elsewhere classified (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
N31.2 - Flaccid neuropathic bladder, not elsewhere classified (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
N31.8 - Other neuromuscular dysfunction of bladder (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
R13 - Dysphagia (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
R06.0 - Dyspnoea (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
R06.8 - Other and unspecified abnormalities of breathing (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
R32 - Unspecified urinary incontinence (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
R33 - Retention of urine (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
R15 - Faecal incontinence (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
S34.0 - Concussion and oedema of lumbar spinal cord (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
S34.1 - Other injury of lumbar spinal cord (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
S34.2 - Injury of nerve root of lumbar and sacral spine (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
S34.3 - Injury of cauda equina (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
S34.4 - Injury of lumbosacral plexus (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
S34.5 - Injury of lumbar, sacral and pelvic sympathetic nerves (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
S34.6 - Injury of peripheral nerve(s) of abdomen, lower back and pelvis (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
S34.8 - Injury of other and unspecified nerves at abdomen, lower back and pelvis level (PMB 213A: Difficulty in breathing, eating, swallowing, bowel, or bladder control due to non-progressive neurological (including spinal) condition or injury)
Q01.0 - Frontal encephalocele (PMB 83A: Encephalocele; congenital hydrocephalus)
Q01.1 - Nasofrontal encephalocele (PMB 83A: Encephalocele; congenital hydrocephalus)
Q01.2 - Occipital encephalocele (PMB 83A: Encephalocele; congenital hydrocephalus)
Q01.8 - Encephalocele of other sites (PMB 83A: Encephalocele; congenital hydrocephalus)
Q01.9 - Encephalocele, unspecified (PMB 83A: Encephalocele; congenital hydrocephalus)
Q03.0 - Malformations of aqueduct of Sylvius (PMB 83A: Encephalocele; congenital hydrocephalus)
Q03.1 - Atresia of foramina of Magendie and Luschka (PMB 83A: Encephalocele; congenital hydrocephalus)
Q03.8 - Other congenital hydrocephalus (PMB 83A: Encephalocele; congenital hydrocephalus)
Q03.9 - Congenital hydrocephalus, unspecified (PMB 83A: Encephalocele; congenital hydrocephalus)
G40.0 - Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.0+F02.8* - Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset/Dementia in other specified diseases classified elsewhere (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.1 - Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.1+F02.8* - Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures/Dementia in other specified diseases classified elsewhere (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.2 - Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.2+F02.8* - Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures/Dementia in other specified diseases classified elsewhere (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.3 - Generalized idiopathic epilepsy and epileptic syndromes (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.3+F02.8* - Generalized idiopathic epilepsy and epileptic syndromes/Dementia in other specified diseases classified elsewhere (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.4 - Other generalized epilepsy and epileptic syndromes (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.4+F02.8* - Other generalized epilepsy and epileptic syndromes/Dementia in other specified diseases classified elsewhere (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.5 - Special epileptic syndromes (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.5+F02.8* - Special epileptic syndromes/Dementia in other specified diseases classified elsewhere (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.6 - Grand mal seizures, unspecified (with or without petit mal) (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.6+F02.8* - Grand mal seizures, unspecified (with or without petit mal)/Dementia in other specified diseases classified elsewhere (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.7 - Petit mal, unspecified, without grand mal seizures (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.7+F02.8* - Petit mal, unspecified, without grand mal seizures/Dementia in other specified diseases classified elsewhere (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.8 - Other epilepsy (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.8+F02.8* - Other epilepsy/Dementia in other specified diseases classified elsewhere (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.9 - Epilepsy, unspecified (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G40.9+F02.8* - Epilepsy, unspecified/Dementia in other specified diseases classified elsewhere (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G41.0 - Grand mal status epilepticus (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G41.1 - Petit mal status epilepticus (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G41.2 - Complex partial status epilepticus (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G41.8 - Other status epilepticus (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
G41.9 - Status epilepticus, unspecified (PMB 902A: Epilepsy (status epilepticus, initial diagnosis, candidate for neurosurgery))
B43.1 - Phaeomycotic brain abscess (PMB 211A: Intraspinal and Intracranial abscess)
A06.6 - Amoebic brain abscess (G07*) (PMB 211A: Intraspinal and Intracranial abscess)
A06.6+G07* - Amoebic brain abscess / Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere (PMB 211A: Intraspinal and Intracranial abscess)
A17.1 - Meningeal tuberculoma (G07*) (PMB 211A: Intraspinal and Intracranial abscess)
A17.1+G07* - Meningeal tuberculoma / Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere (PMB 211A: Intraspinal and Intracranial abscess)
A17.8+G07* - Other tuberculosis of nervous system / Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere (PMB 211A: Intraspinal and Intracranial abscess)
B65.0+G07* - Schistosomiasis due to Schistosoma haematobium [urinary schistosomiasis]/Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere (PMB 211A: Intraspinal and Intracranial abscess)
B65.1+G07* - Schistosomiasis due to Schistosoma mansoni [intestinal schistosomiasis]/Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere (PMB 211A: Intraspinal and Intracranial abscess)
B65.2+G07* - Schistosomiasis due to Schistosoma japonicum/Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere (PMB 211A: Intraspinal and Intracranial abscess)
B65.3+G07* - Cercarial dermatitis/Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere (PMB 211A: Intraspinal and Intracranial abscess)
B65.8+G07* - Other schistosomiases/Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere (PMB 211A: Intraspinal and Intracranial abscess)
B65.9+G07* - Schistosomiasis, unspecified/Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere (PMB 211A: Intraspinal and Intracranial abscess)
G06.0 - Intracranial abscess and granuloma (PMB 211A: Intraspinal and Intracranial abscess)
G06.1 - Intraspinal abscess and granuloma (PMB 211A: Intraspinal and Intracranial abscess)
G06.2 - Extradural and subdural abscess unspecified (PMB 211A: Intraspinal and Intracranial abscess)
A17.0 - Tuberculous meningitis (G01*) (PMB 905A: Meningitis – acute and subacute)
A17.0+G01* - Tuberculous meningitis / Meningitis in bacterial diseases classified elsewhere (PMB 905A: Meningitis – acute and subacute)
A32.1 - Listerial meningitis and meningoencephalitis (PMB 905A: Meningitis – acute and subacute)
A32.1+G01* - Listerial meningitis and meningoencephalitis/Meningitis in bacterial diseases classified elsewhere (PMB 905A: Meningitis – acute and subacute)
A39.0 - Meningococcal meningitis (G01*) (PMB 905A: Meningitis – acute and subacute)
A39.0+G01* - Meningococcal meningitis (G01*)/Meningitis in bacterial diseases classified elsewhere (PMB 905A: Meningitis – acute and subacute)
A52.1+G01* - Symptomatic neurosyphilis/Meningitis in bacterial diseases classified elsewhere (PMB 905A: Meningitis – acute and subacute)
B37.5 - Candidal meningitis (G02.1*) (PMB 905A: Meningitis – acute and subacute)
B37.5+G02.1* - Candidal meningitis/ Meningitis in mycosis (PMB 905A: Meningitis – acute and subacute)
B38.4+G02.1* - Coccidioidomycosis meningitis / Meningitis in mycoses (PMB 905A: Meningitis – acute and subacute)
B45.1+G02.1* - Cerebral cryptococcosis/Meningitis in mycoses (PMB 905A: Meningitis – acute and subacute)
G00.0 - Haemophilus meningitis (PMB 905A: Meningitis – acute and subacute)
G00.1 - Pneumococcal meningitis (PMB 905A: Meningitis – acute and subacute)
G00.2 - Streptococcal meningitis (PMB 905A: Meningitis – acute and subacute)
G00.3 - Staphylococcal meningitis (PMB 905A: Meningitis – acute and subacute)
G00.8 - Other bacterial meningitis (PMB 905A: Meningitis – acute and subacute)
G00.9 - Bacterial meningitis unspecified (PMB 905A: Meningitis – acute and subacute)
G01 - Meningitis in bacterial diseases classified elsewhere (PMB 905A: Meningitis – acute and subacute)
G02.0 - Meningitis in viral diseases classified elsewhere (PMB 905A: Meningitis – acute and subacute)
G02.1 - Meningitis in mycoses (PMB 905A: Meningitis – acute and subacute)
G02.8 - Meningitis in other specified infectious and parasitic diseases classified elsewhere (PMB 905A: Meningitis – acute and subacute)
G03.0 - Nonpyogenic meningitis (PMB 905A: Meningitis – acute and subacute)
G03.1 - Chronic meningitis (PMB 905A: Meningitis – acute and subacute)
G03.2 - Benign recurrent meningitis [Mollaret] (PMB 905A: Meningitis – acute and subacute)
G03.8 - Meningitis due to other specified causes (PMB 905A: Meningitis – acute and subacute)
G03.9 - Meningitis, unspecified (PMB 905A: Meningitis – acute and subacute)
G04.2 - Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified (PMB 905A: Meningitis – acute and subacute)
G13.0 - Paraneoplastic neuromyopathy and neuropathy (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G13.8 - Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G37.8 - Other specified demyelinating diseases of central nervous system (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G37.9 - Demyelinating disease of central nervous system, unspecified (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G70.0 - Myasthenia gravis (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G70.1 - Toxic myoneural disorders (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G70.2 - Congenital and developmental myasthenia (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G70.8 - Other specified myoneural disorders (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G70.9 - Myoneural disorder unspecified (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G71.0 - Muscular dystrophy (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G71.1 - Myotonic disorders (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G71.2 - Congenital myopathies (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G71.3 - Mitochondrial myopathy not elsewhere classified (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G71.8 - Other primary disorders of muscles (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G71.9 - Primary disorder of muscle unspecified (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G72.0 - Drug-induced myopathy (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G72.1 - Alcoholic myopathy (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G72.2 - Myopathy due to other toxic agents (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G72.4 - Inflammatory myopathy, not elsewhere classified (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G72.8 - Other specified myopathies (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G72.9 - Myopathy, unspecified (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G73.0 - Myasthenic syndromes in endocrine diseases (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G73.1 - Eaton-Lambert syndrome (C00-D48+) (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G73.2 - Other myasthenic syndromes in neoplastic disease (C00-D48+) (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G73.3 - Myasthenic syndromes in other diseases classified elsewhere (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G73.4 - Myopathy in infectious and parasitic diseases classified elsewhere (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G73.5 - Myopathy in endocrine diseases (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G73.6 - Myopathy in metabolic diseases (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
G73.7 - Myopathy in other diseases classified elsewhere (PMB 513A: Myasthenia gravis; muscular dystrophy; neuro-myopathies NOS)
S14.4 - Injury of peripheral nerves of neck (PMB 510A: Peripheral nerve injury with open wound)
S24.3 - Injury of peripheral nerves of thorax (PMB 510A: Peripheral nerve injury with open wound)
S24.4 - Injury of thoracic sympathetic nerves (PMB 510A: Peripheral nerve injury with open wound)
S24.5 - Injury of other nerves of thorax (PMB 510A: Peripheral nerve injury with open wound)
S24.6 - Injury of unspecified nerve of thorax (PMB 510A: Peripheral nerve injury with open wound)
S34.6 - Injury of peripheral nerve(s) of abdomen, lower back and pelvis (PMB 510A: Peripheral nerve injury with open wound)
S34.8 - Injury of other and unspecified nerves at abdomen, lower back and pelvis level (PMB 510A: Peripheral nerve injury with open wound)
S44.0 - Injury of ulnar nerve at upper arm level (PMB 510A: Peripheral nerve injury with open wound)
S44.1 - Injury of median nerve at upper arm level (PMB 510A: Peripheral nerve injury with open wound)
S44.2 - Injury of radial nerve at upper arm level (PMB 510A: Peripheral nerve injury with open wound)
S44.3 - Injury of axillary nerve (PMB 510A: Peripheral nerve injury with open wound)
S44.4 - Injury of musculocutaneous nerve (PMB 510A: Peripheral nerve injury with open wound)
S44.5 - Injury of cutaneous sensory nerve at shoulder and upper arm level (PMB 510A: Peripheral nerve injury with open wound)
S44.7 - Injury of multiple nerves at shoulder and upper arm level (PMB 510A: Peripheral nerve injury with open wound)
S44.8 - Injury of other nerves at shoulder and upper arm level (PMB 510A: Peripheral nerve injury with open wound)
S44.9 - Injury of unspecified nerve at shoulder and upper arm level (PMB 510A: Peripheral nerve injury with open wound)
S54.0 - Injury of ulnar nerve at forearm level (PMB 510A: Peripheral nerve injury with open wound)
S54.1 - Injury of median nerve at forearm level (PMB 510A: Peripheral nerve injury with open wound)
S54.2 - Injury of radial nerve at forearm level (PMB 510A: Peripheral nerve injury with open wound)
S54.3 - Injury of cutaneous sensory nerve at forearm level (PMB 510A: Peripheral nerve injury with open wound)
S54.7 - Injury of multiple nerves at forearm level (PMB 510A: Peripheral nerve injury with open wound)
S54.8 - Injury of other nerves at forearm level (PMB 510A: Peripheral nerve injury with open wound)
S54.9 - Injury of unspecified nerve at forearm level (PMB 510A: Peripheral nerve injury with open wound)
S64.0 - Injury of ulnar nerve at wrist and hand level (PMB 510A: Peripheral nerve injury with open wound)
S64.1 - Injury of median nerve at wrist and hand level (PMB 510A: Peripheral nerve injury with open wound)
S64.2 - Injury of radial nerve at wrist and hand level (PMB 510A: Peripheral nerve injury with open wound)
S64.3 - Injury of digital nerve of thumb (PMB 510A: Peripheral nerve injury with open wound)
S64.4 - Injury of digital nerve of other finger (PMB 510A: Peripheral nerve injury with open wound)
S64.7 - Injury of multiple nerves at wrist and hand level (PMB 510A: Peripheral nerve injury with open wound)
S64.8 - Injury of other nerves at wrist and hand level (PMB 510A: Peripheral nerve injury with open wound)
S64.9 - Injury of unspecified nerve at wrist and hand level (PMB 510A: Peripheral nerve injury with open wound)
S74.0 - Injury of sciatic nerve at hip and thigh level (PMB 510A: Peripheral nerve injury with open wound)
S74.1 - Injury of femoral nerve at hip and thigh level (PMB 510A: Peripheral nerve injury with open wound)
S74.2 - Injury of cutaneous sensory nerve at hip and thigh level (PMB 510A: Peripheral nerve injury with open wound)
S74.7 - Injury of multiple nerves at hip and thigh level (PMB 510A: Peripheral nerve injury with open wound)
S74.8 - Injury of other nerves at hip and thigh level (PMB 510A: Peripheral nerve injury with open wound)
S74.9 - Injury of unspecified nerve at hip and thigh level (PMB 510A: Peripheral nerve injury with open wound)
S84.0 - Injury of tibial nerve at lower leg level (PMB 510A: Peripheral nerve injury with open wound)
S84.1 - Injury of peroneal nerve at lower leg level (PMB 510A: Peripheral nerve injury with open wound)
S84.2 - Injury of cutaneous sensory nerve at lower leg level (PMB 510A: Peripheral nerve injury with open wound)
S84.7 - Injury of multiple nerves at lower leg level (PMB 510A: Peripheral nerve injury with open wound)
S84.8 - Injury of other nerves at lower leg level (PMB 510A: Peripheral nerve injury with open wound)
S84.9 - Injury of unspecified nerve at lower leg level (PMB 510A: Peripheral nerve injury with open wound)
S94.0 - Injury of lateral plantar nerve (PMB 510A: Peripheral nerve injury with open wound)
S94.1 - Injury of medial plantar nerve (PMB 510A: Peripheral nerve injury with open wound)
S94.2 - Injury of deep peroneal nerve at ankle and foot level (PMB 510A: Peripheral nerve injury with open wound)
S94.3 - Injury of cutaneous sensory nerve at ankle and foot level (PMB 510A: Peripheral nerve injury with open wound)
S94.7 - Injury of multiple nerves at ankle and foot level (PMB 510A: Peripheral nerve injury with open wound)
S94.8 - Injury of other nerves at ankle and foot level (PMB 510A: Peripheral nerve injury with open wound)
S94.9 - Injury of unspecified nerve at ankle and foot level (PMB 510A: Peripheral nerve injury with open wound)
T11.3 - Injury of unspecified nerve of upper limb, level unspecified (PMB 510A: Peripheral nerve injury with open wound)
T13.3 - Injury of unspecified nerve of lower limb, level unspecified (PMB 510A: Peripheral nerve injury with open wound)
T14.4 - Injury of nerve(s) of unspecified body region (PMB 510A: Peripheral nerve injury with open wound)
T92.4 - Sequelae of injury of nerve of upper limb (PMB 510A: Peripheral nerve injury with open wound)
T93.4 - Sequelae of injury of nerve of lower limb (PMB 510A: Peripheral nerve injury with open wound)
G25.1 - Drug-induced tremor (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
G25.3 - Myoclonus (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
G25.4 - Drug-induced chorea (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
G25.5 - Other chorea (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
G25.6 - Drug-induced tics and other tics of organic origin (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R25.0 - Abnormal head movements (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R25.1 - Tremor, unspecified (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R25.2 - Cramp and spasm (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R25.3 - Fasciculation (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R25.8 - Other and unspecified abnormal involuntary movements (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R26.0 - Ataxic gait (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R26.1 - Paralytic gait (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R26.2 - Difficulty in walking, not elsewhere classified (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R26.3 - Immobility (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R26.8 - Other and unspecified abnormalities of gait and mobility (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R27.0 - Ataxia, unspecified (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R27.8 - Other and unspecified lack of coordination (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R29.0 - Tetany (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R29.1 - Meningismus (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R29.2 - Abnormal reflex (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R29.3 - Abnormal posture (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R29.4 - Clicking hip (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R29.6 - Tendency to fall, not elsewhere classified (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
R29.8 - Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems (PMB 940A: Reversible CNS abnormalities due to other systemic disease)
G93.5 - Compression of brain (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
G93.6 - Cerebral oedema (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
G96.0 - Cerebrospinal fluid leak (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.00 - Concussion without open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.01 - Concussion with open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.10 - Traumatic cerebral oedema without open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.11 - Traumatic cerebral oedema with open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.20 - Diffuse brain injury without open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.21 - Diffuse brain injury with open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.30 - Focal brain injury without open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.31 - Focal brain injury with open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.40 - Epidural haemorrhage without open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.41 - Epidural haemorrhage with open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.50 - Traumatic subdural haemorrhage without open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.51 - Traumatic subdural haemorrhage with open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.60 - Traumatic subarachnoid haemorrhage without open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.61 - Traumatic subarachnoid haemorrhag with open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.70 - Intracranial injury with prolonged coma without open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.71 - Intracranial injury with prolonged coma with open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.80 - Other intrcranial injury without open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / oedema with loss of consciousness)
S06.81 - Other intrcranial injury with open intracranial injury (PMB 1A: Severe / moderate head injury: hematoma / o
Claim or Authorisation Reference Number
*
Scheme's Stated Reason for Decline/Dispute
*
Specific Benefit Option/Plan Name
*
Date of Service
*
-
Month
-
Day
Year
2 digit month, 2 digit day, 4 digit year
Date
Date of Decline
*
-
Month
-
Day
Year
2 digit month, 2 digit day, 4 digit year
Date
Urgency Indicator
*
Low
Medium
High
Critical
Amount/Cost in Dispute
*
Facility/Hospital Name
*
Prior Escalation History
*
Nature of Complaint
*
Supporting Documents (Pathology, Histopathology, MRI,CT, Motivational Letters etc - Maximum File Size 10 Meg)
*
Upload a File
Drag and drop files here
Choose a file
Cancel
of
Consent Confirmation
*
By signing below, I confirm that I am the treating doctor and have obtained the patient's consent to complete and submit this form directly to MediCheck on their behalf.
Doctor's Signature
*
Save
Submit to MediCheck
Submit to MediCheck
Should be Empty: